The Pharma Career Ladder · The country manager · Step 4: Distributors and market access · Lesson 16

Compliance is a commercial asset

Why the strict company wins long term

By Ahmed El Menshawy · 20 years in pharma, from medical rep to country manager in the UAE. Founder of RepPharma. LinkedIn
Published

In many teams, compliance is the department that says no.

It arrives at the end, reviews what is already decided, and slows things down. At least that is how it often feels from the commercial side.

I see it differently now. In my experience, a strictly compliant company earns something no budget can buy.

Look at where the shortcut and the strict way part.

With doctors. The shortcut is hospitality that edges past the code. The strict way offers scientific value only.

Advisory boards. The shortcut is an invitation as a reward. The strict way needs a documented need, the right experts and fair-market-value fees.

Medical questions. The shortcut lets reps answer off-label questions themselves. The strict way refers every one to medical affairs.

Adverse events. The shortcut mentions them later, if anyone remembers. The strict way reports them promptly, every time.

In the long run, the shortcut brings investigations, lost trust and lost people. The strict way earns the trust of doctors, authorities and the good people who want to work somewhere clean.

Customers notice. They remember which company never asked them to bend a rule.

So I try to bring compliance in at the start, not the end. Leaders set the tone, and the team watches what we allow far more than what we say.

“The shortcut wins a quarter. Trust wins the market.”
Compliance is a commercial asset: Why the strict company wins long term

Lesson 16 of 17 in Step 4: Distributors and market access, with the full guide and a checklist for this week.

More lessons in step 4: Distributors and market access

Distributors and market access, in RepPharma

Targets split by rep, product and month

Yearly targets are split by rep, product and month, and sales credit can be moved between reps without changing the company total.

Distributor stock and sell-out

Distributor stock and pharmacy sell-out side by side, with short-expiry lots flagged up to 90 days ahead.

One system for the whole field force

Visits, plans, forecasts, samples, expenses, leaves and approvals, with role-based access from rep to country manager.

A new step every week in the Pharma Career Ladder newsletter on LinkedIn.